Research Advances in Targeted Therapy for Heart Failure
- PMID: 39077559
- PMCID: PMC11262442
- DOI: 10.31083/j.rcm2410276
Research Advances in Targeted Therapy for Heart Failure
Abstract
Cardiovascular disease is one of the major diseases threatening the health of Chinese residents, and the death rate has long been the highest on the disease spectrum in China. With the progress of population aging, the prevalence and mortality of cardiovascular diseases remain on the rise, and the current treatment effect on and prognosis of heart failure (HF) are not satisfactory. It is particularly important to explore the potential pathogenic mechanisms of HF and identify new therapeutic targets.
Keywords: HF; gene therapy; intestinal flora; mitochondrial autophagy; signaling channels; targeted therapy.
Copyright: © 2023 The Author(s). Published by IMR Press.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Ahmad AF, Ward NC, Dwivedi G. The gut microbiome and heart failure. Current Opinion in Cardiology . 2019;34:225–232. - PubMed
-
- Marques FZ, Nelson E, Chu PY, Horlock D, Fiedler A, Ziemann M, et al. High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice. Circulation . 2017;135:964–977. - PubMed
-
- Salehi-Abargouei A, Maghsoudi Z, Shirani F, Azadbakht L. Effects of Dietary Approaches to Stop Hypertension (DASH)-style diet on fatal or nonfatal cardiovascular diseases–incidence: a systematic review and meta-analysis on observational prospective studies. Nutrition . 2013;29:611–618. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
